Valuation: Bachem Holding AG

Capitalization 3.87B 4.84B 4.17B 3.68B 6.78B 428B 7.42B 45.78B 17.67B 204B 18.16B 17.78B 746B P/E ratio 2025 *
33.8x
P/E ratio 2026 * 22.1x
Enterprise value 4.09B 5.12B 4.41B 3.89B 7.17B 453B 7.84B 48.4B 18.67B 216B 19.19B 18.8B 788B EV / Sales 2025 *
5.98x
EV / Sales 2026 * 4.54x
Free-Float
94.31%
Yield 2025 *
1.79%
Yield 2026 * 1.94%
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.34%
1 week-0.19%
Current month-9.96%
1 month-7.90%
3 months-22.98%
Current year-9.41%
More quotes
1 week 50.7
Extreme 50.7
53
1 month 50.7
Extreme 50.7
59.95
Current year 43.34
Extreme 43.34
76
1 year 43.34
Extreme 43.34
76
3 years 43.34
Extreme 43.34
105.6
5 years 43.34
Extreme 43.34
171
10 years 9.89
Extreme 9.89
171
More quotes
Manager TitleAgeSince
Chief Executive Officer 57 2019-12-31
Director of Finance/CFO 48 2021-01-31
Chief Tech/Sci/R&D Officer - 2002-12-31
Director TitleAgeSince
Director/Board Member 52 2011-04-12
Chairman 69 2012-04-24
Director/Board Member 56 2014-04-27
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+0.34%-0.19%-29.74%-38.73% 4.84B
+0.51%+3.64%-0.14%+9.71% 48.54B
+4.39%+11.15%+67.60%+73.60% 38.03B
-0.00%+2.61%-0.24%-4.45% 37.22B
-0.46%-1.99%+8.38%+2.21% 26.05B
+0.39%+1.39%+65.79%+172.61% 16.98B
-0.31%-15.30%-7.81% - 12.73B
+2.15%+9.41%+5.74%+189.04% 12.39B
+3.64%+0.28%-22.98%-26.21% 12.48B
+2.63%-3.40%+56.67%+52.43% 12.29B
Average +1.50%-0.10%+14.33%+47.80% 22.15B
Weighted average by Cap. +1.55%+1.48%+18.63%+41.02%
See all sector performances

Financials

2025 *2026 *
Net sales 685M 856M 738M 650M 1.2B 75.7B 1.31B 8.09B 3.12B 36.14B 3.21B 3.14B 132B 962M 1.2B 1.04B 913M 1.68B 106B 1.84B 11.37B 4.39B 50.78B 4.51B 4.42B 185B
Net income 116M 145M 125M 110M 203M 12.79B 221M 1.37B 528M 6.11B 542M 531M 22.27B 179M 224M 193M 170M 313M 19.77B 342M 2.11B 816M 9.44B 838M 821M 34.42B
Net Debt 221M 277M 239M 210M 388M 24.47B 424M 2.62B 1.01B 11.68B 1.04B 1.02B 42.61B 498M 623M 537M 473M 873M 55.1B 954M 5.89B 2.27B 26.31B 2.34B 2.29B 95.95B
More financial data * Estimated data
Logo Bachem Holding AG
Bachem Holding AG is a Switzerland-based biochemical company that provides services to the pharmaceutical and biotechnology industry. The Company focuses on the process development and manufacturing of peptides and organic molecules as active pharmaceutical ingredients (APIs), as well as on the development of biochemical products for research purposes. Its product portfolio comprises fluorescent dyes for the fluorescence energy transfer (FRET) analysis of receptor-ligand interactions, protein-protein interactions and the cleavage of substrate molecules, as well as glycosylated peptides for the manipulation of drug properties. The Company markets products under the Bachem and Clinalfa brands and operates production facilities in Switzerland and in the United States.
Employees
2,292
More about the company
Date Price Change Volume
25-11-12 51.95 CHF +0.58% 15,963
25-11-11 51.65 CHF +0.88% 88,466
25-11-10 51.20 CHF +0.49% 51,343
25-11-07 50.95 CHF 0.00% 123,030
25-11-06 50.95 CHF -3.04% 100,437

Delayed Quote Swiss Exchange, November 12, 2025 at 03:01 am EST

More quotes
Trader
Investor
Global
Quality
ESG MSCI
BBB
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
51.65CHF
Average target price
74.69CHF
Spread / Average Target
+44.61%
Consensus

Quarterly revenue - Rate of surprise